Chong Kun Dang Pharmaceutical Corp.: debt-to-equity, ROE and more
KOSPI, Legal name Chong Kun Dang Pharmaceutical Corp.
Latest figures are the FY2025 consolidated summary statements.
Latest fiscal year ratios (computed here)
- Debt/equity
- 78.9%
- Equity ratio
- 55.9%
- ROE
- 7.7%
- Op. margin
- 4.8%
- Rev. growth
- 6.7%
- Interest coverage
- n/a
Condition flags
- Operating profit for 5 straight years.
- Total equity is above paid-in capital. Not capital-impaired.
Interest coverage and dividends (OpenDART)
Interest expense and dividends come from DART's OpenDART annual-report filings, not the FSC summary statements used above. The source differs from the other tables on this page.
Interest coverage = operating profit ÷ interest expenseNo interest expense value yet for this company. Most companies fold interest expense into a single finance-costs line on their income statement, so it cannot be pulled out separately. Interest coverage is not computed here.
Dividends, last 3 fiscal years
| Fiscal year | Cash dividend per share | Payout ratio |
|---|---|---|
| 2025 | ₩500 | 8.5% |
| 2024 | ₩1,100 | 12.7% |
| 2023 | ₩1,100 | 6.3% |
Cash dividends for 3 straight years (only the 3 years OpenDART returns).
Source values from the OpenDART (금융감독원 전자공시) annual report. Report fiscal year 2025.
Ratios by year (computed here)
Debt-to-equity = total liabilities ÷ total equity × 100Equity ratio = total equity ÷ total assets × 100ROE = net income ÷ year-end total equity × 100Operating margin = operating profit ÷ revenue × 100Revenue growth = (this year − last year) ÷ last year × 100
Computed from the source figures above with these formulas. Where the source's own debt-to-equity differs from ours, both are shown for that year.
| Fiscal year | Debt/equity | Equity ratio | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| FY2021 consolidated | 85.0% | 54.1% | 7.5% | 7.1% | n/a |
| FY2022 consolidated | 81.1% | 55.2% | 12.9% | 7.4% | 10.8% |
| FY2023 consolidated | 71.9% | 58.2% | 26.2% | 14.8% | 12.2% |
| FY2024 consolidated | 62.7% | 61.4% | 12.4% | 6.3% | -5.0% |
| FY2025 consolidated | 78.9% | 55.9% | 7.7% | 4.8% | 6.7% |
Source figures (FSC summary statements)
Amounts are the source values, shortened. A cell reported as zero may be blank in the source, so it is not used in any ratio.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | ₩1.34T | ₩1.49T | ₩1.67T | ₩1.59T | ₩1.69T |
| Operating profit | ₩94.8B | ₩109.9B | ₩246.6B | ₩99.5B | ₩80.6B |
| Pre-tax income | ₩80.6B | ₩97.2B | ₩241.6B | ₩102.0B | ₩81.7B |
| Net income | ₩42.4B | ₩80.0B | ₩213.6B | ₩111.4B | ₩77.8B |
| Total assets | ₩1.05T | ₩1.12T | ₩1.40T | ₩1.46T | ₩1.80T |
| Total liabilities | ₩480.9B | ₩503.6B | ₩586.8B | ₩562.4B | ₩793.9B |
| Total equity | ₩565.8B | ₩621.3B | ₩815.6B | ₩896.4B | ₩1.01T |
| Paid-in capital | ₩28.6B | ₩30.0B | ₩31.4B | ₩32.9B | ₩34.5B |
| Debt/equity (source value) | 85.0% | 81.1% | 71.9% | 62.7% | 78.9% |
Company outline (FSC)
- Market
- KOSPI
- Fiscal year end
- Dec
- Founded
- 2013-11-05
- Listed
- 13/12/06
- Employees
- 2,304
- Auditor
- 안진회계법인
- Audit opinion
- 적정의견
- Corporate reg. no.
- 1101115260669
- Outline updated
- 2026-09-24
Check the original filings
Read the annual report and audit report before you decide anything. The link opens a DART search for this company's name.
Search DART for 종근당Computed from the Financial Services Commission's company outline and summary statements (data.go.kr). Data as of 2026-09-24.